Valeant Pharmaceuticals (Filler And Toxin Assets) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Valeant Pharmaceuticals (Filler And Toxin Assets) General Information

Description

Filler and Toxin Assets in Laval, Canada. The Filler and Toxin Assets such as Restylane, Perlane, Emervel, Sculptra, and Dysport is produced and distributed in Laval, Canada.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 2150 Street Elzéar boulevard West
  • Laval, Quebec H7L 4A8
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Valeant Pharmaceuticals (Filler And Toxin Assets) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Valeant Pharmaceuticals (Filler And Toxin Assets)‘s full profile, request access.

Request a free trial

Valeant Pharmaceuticals (Filler And Toxin Assets) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Valeant Pharmaceuticals (Filler And Toxin Assets)‘s full profile, request access.

Request a free trial